Market Cap (In INR)
43.23 Billion
Revenue (In INR)
26.15 Billion
Net Income (In INR)
-1.53 Billion
Avg. Volume
1.03 Million
- Currency
- INR
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 133.0-307.98
- PE
- -
- EPS
- -
- Beta Value
- 1.236
- ISIN
- INE385W01011
- CUSIP
- Y1R03Y104
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Pascal Villemagne
- Employee Count
- -
- Website
- https://imdcal.com
- Ipo Date
- 2004-04-22
- Details
- Dishman Carbogen Amcis Limited provides contract research and manufacturing services to the pharmaceutical industry worldwide. The company operates through Contract Research and Manufacturing Services and Marketable Molecules segments. It also manufactures and supplies bulk drugs, intermediates, phase transfer catalysts, quaternary ammonium compounds, phosphoranes, wittig reagents, vitamin D products, fine chemicals, hand and body wash, sanitisers, antiseptics, and various pharmaceutical and cosmetic-related products, as well as generic and highly potent active pharmaceutical ingredients. The company was incorporated in 1983 and is headquartered in Ahmedabad, India. Dishman Carbogen Amcis Limited is a subsidiary of Adimans Technologies LLP.
More Stocks
-
7744
-
TVPKFTravis Perkins plc
TVPKF
-
002999
-
4IG4iG Nyrt.
4IG
-
CENTRUMCentrum Capital Limited
CENTRUM
-
ATEAYAtea ASA
ATEAY
-
APNHY
-
PIONAGRPIONEER AGRO EXTRACTS LTD.
PIONAGR